RNS Number : 2162N
FTSE Russell
03 May 2024
 

 


 

E-therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

03 May 2024

Subject to the expected cancellation of trading on AIM for E-therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective From
Start of Trading

FTSE AIM All-Share Index

09 May 2024

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:


Australia


+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

                                   

 

Alternatively please visit our website at lseg.com/ftse-russell

 


 Terms of Use | Copyright © 2024 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSBBGDUGBGDGSX
E-therapeutics (LSE:ETX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse E-therapeutics
E-therapeutics (LSE:ETX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse E-therapeutics